Tributary Capital Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Tributary Capital Management, LLC

$1.15 Billion
Q1 2025

A detailed history of Tributary Capital Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tributary Capital Management, LLC holds 331,979 shares of SUPN stock, worth $10.6 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

331,979

Previous 343,962 3.48%

Holding current value

$10.6 Million

Previous $12.4 Million 12.58%

% of portfolio

0.95%

Previous 0.96%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$31.17 - $40.0 $373,510 - $479,320	-11,983 Reduced 3.48%	331,979 $10.9 Million
Q4 2024 Jan 21, 2025	SELL	$31.89 - $37.83 $11,384 - $13,505	-357 Reduced 0.1%	343,962 $12.4 Million
Q3 2024 Oct 24, 2024	SELL	$25.77 - $35.16 $20,667 - $28,198	-802 Reduced 0.23%	344,319 $10.7 Million
Q2 2024 Jul 24, 2024	BUY	$25.99 - $33.85 $7,355 - $9,579	283 Added 0.08%	345,121 $9.23 Million
Q1 2024 Apr 18, 2024	SELL	$27.11 - $35.17 $38,577 - $50,046	-1,423 Reduced 0.41%	344,838 $11.8 Million
Q4 2023 Jan 16, 2024	SELL	$22.72 - $29.68 $140,136 - $183,066	-6,168 Reduced 1.75%	346,261 $10 Million
Q3 2023 Oct 11, 2023	BUY	$27.57 - $32.91 $115,490 - $137,859	4,189 Added 1.2%	352,429 $9.72 Million
Q2 2023 Jul 17, 2023	SELL	$29.91 - $38.73 $162,441 - $210,342	-5,431 Reduced 1.54%	348,240 $10.5 Million
Q1 2023 Apr 26, 2023	BUY	$34.93 - $42.03 $399,773 - $481,033	11,445 Added 3.34%	353,671 $12.8 Million
Q4 2022 Jan 27, 2023	SELL	$31.09 - $37.88 $397,889 - $484,788	-12,798 Reduced 3.6%	342,226 $12.2 Million
Q3 2022 Oct 11, 2022	SELL	$28.79 - $35.41 $157,164 - $193,303	-5,459 Reduced 1.51%	355,024 $12 Million
Q2 2022 Jul 19, 2022	BUY	$25.33 - $34.25 $598,725 - $809,567	23,637 Added 7.02%	360,483 $10.4 Million
Q1 2022 Apr 22, 2022	BUY	$28.51 - $32.9 $459,125 - $529,821	16,104 Added 5.02%	336,846 $10.9 Million
Q4 2021 Jan 06, 2022	SELL	$26.37 - $34.22 $524,103 - $680,122	-19,875 Reduced 5.83%	320,742 $9.35 Million
Q3 2021 Oct 14, 2021	BUY	$23.54 - $31.39 $929,312 - $1.24 Million	39,478 Added 13.11%	340,617 $9.08 Million
Q2 2021 Jul 15, 2021	SELL	$26.72 - $33.19 $376,805 - $468,045	-14,102 Reduced 4.47%	301,139 $9.27 Million
Q1 2021 Apr 20, 2021	BUY	$24.15 - $31.45 $7.61 Million - $9.91 Million	315,241 New	315,241 $8.25 Million

Others Institutions Holding SUPN

# of Institutions

305

Shares Held

60.8M

Call Options Held

8.8K

Put Options Held

6.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.71B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Account

Tributary Capital Management, LLC Supernus Pharmaceuticals, Inc. Transaction History